BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 30547811)

  • 1. Endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer: choice of new approach.
    Suzuki G; Yamazaki H; Aibe N; Masui K; Sasaki N; Shimizu D; Kimoto T; Shiozaki A; Dohi O; Fujiwara H; Ishikawa T; Konishi H; Naito Y; Otsuji E; Yamada K
    Radiat Oncol; 2018 Dec; 13(1):246. PubMed ID: 30547811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effectiveness of endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer.
    Kawaguchi G; Sasamoto R; Abe E; Ohta A; Sato H; Tanaka K; Maruyama K; Kaizu M; Ayukawa F; Yamana N; Liu J; Takeuchi M; Kobayashi M; Aoyama H
    Radiat Oncol; 2015 Jan; 10():31. PubMed ID: 25636830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
    Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
    Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophagectomy versus definitive chemoradiotherapy for patients with clinical stage N0 and pathological stage T1b esophageal squamous cell carcinoma after endoscopic submucosal dissection: study protocol for a multicenter randomized controlled trial (Ad-ESD Trial).
    Yang Y; Su Y; Zhang X; Liu J; Zhang H; Li B; Hua R; Tan L; Chen H; Li Z
    Trials; 2020 Jul; 21(1):603. PubMed ID: 32611448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoscopic Submucosal Dissection (ESD) with Additional Therapy for Superficial Esophageal Cancer with Submucosal Invasion.
    Ikeda A; Hoshi N; Yoshizaki T; Fujishima Y; Ishida T; Morita Y; Ejima Y; Toyonaga T; Kakechi Y; Yokosaki H; Azuma T
    Intern Med; 2015; 54(22):2803-13. PubMed ID: 26567992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the clinical outcomes of esophagectomy and chemoradiotherapy after noncurative endoscopic submucosal dissection for esophageal squamous cell carcinoma.
    Koterazawa Y; Nakamura T; Oshikiri T; Kanaji S; Tanaka S; Ishida T; Yamashita K; Matsuda T; Morita Y; Suzuki S; Kakeji Y
    Surg Today; 2018 Aug; 48(8):783-789. PubMed ID: 29532261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control.
    Hisano O; Nonoshita T; Hirata H; Sasaki T; Watanabe H; Wakiyama H; Ono M; Ohga S; Honda H
    Radiat Oncol; 2018 Jan; 13(1):14. PubMed ID: 29378603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic resection with adjuvant chemo-radiotherapy for superficial esophageal squamous cell carcinoma: A critical review.
    Kam TY; Kountouri M; Roth A; Frossard JL; Huber O; Mönig S; Zilli T
    Crit Rev Oncol Hematol; 2018 Apr; 124():61-65. PubMed ID: 29548487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes of combined endoscopic resection and chemoradiotherapy for esophageal squamous cell carcinoma with submucosal invasion.
    Yoshimizu S; Yoshio T; Ishiyama A; Tsuchida T; Horiuchi Y; Omae M; Hirasawa T; Asari T; Chin K; Fujisaki J
    Dig Liver Dis; 2018 Aug; 50(8):833-838. PubMed ID: 29477349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoradiation versus surgery for superficial esophageal squamous cell carcinoma after noncurative endoscopic submucosal dissection: comparison of long-term oncologic outcomes.
    Suzuki G; Yamazaki H; Aibe N; Masui K; Kimoto T; Nagasawa S; Watanabe S; Seri S; Asato A; Shiozaki A; Fujiwara H; Konishi H; Dohi O; Ishikawa T; Elsaleh H; Yamada K
    Radiat Oncol; 2022 Nov; 17(1):191. PubMed ID: 36401267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Clinical T1N0M0 Esophageal Cancer.
    Yang AJ; Choi SH; Byun HK; Kim HJ; Choi J; Lee YC; Lee SK; Park KR; Lee CG
    Gut Liver; 2019 May; 13(3):315-324. PubMed ID: 30600672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between radical esophagectomy and definitive chemoradiotherapy in patients with clinical T1bN0M0 esophageal cancer.
    Motoori M; Yano M; Ishihara R; Yamamoto S; Kawaguchi Y; Tanaka K; Kishi K; Miyashiro I; Fujiwara Y; Shingai T; Noura S; Ohue M; Ohigashi H; Nakamura S; Ishikawa O
    Ann Surg Oncol; 2012 Jul; 19(7):2135-41. PubMed ID: 22302264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of transthoracic esophagectomy with definitive chemoradiotherapy as initial treatment for patients with esophageal squamous cell carcinoma who could tolerate transthoracic esophagectomy.
    Matsuda S; Tsubosa Y; Niihara M; Sato H; Takebayashi K; Kawamorita K; Mori K; Tsushima T; Yokota T; Ogawa H; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
    Ann Surg Oncol; 2015; 22(6):1866-73. PubMed ID: 25564176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.
    Sgourakis G; Gockel I; Lang H
    World J Gastroenterol; 2013 Mar; 19(9):1424-37. PubMed ID: 23539431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and meta-analysis on the significance of salvage esophagectomy for persistent or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy.
    Kumagai K; Mariosa D; Tsai JA; Nilsson M; Ye W; Lundell L; Rouvelas I
    Dis Esophagus; 2016 Oct; 29(7):734-739. PubMed ID: 26316181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical outcome of endoscopic mucosal resection for esophageal squamous cell cancer invading muscularis mucosa and submucosal layer.
    Yoshii T; Ohkawa S; Tamai S; Kameda Y
    Dis Esophagus; 2013 Jul; 26(5):496-502. PubMed ID: 22676622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of adjuvant chemoradiotherapy after endoscopic treatment of early-stage esophageal cancer: a systematic review.
    Goense L; Meziani J; Borggreve AS; van Rossum PS; Meijer GJ; Ruurda JP; van Hillegersberg R; Weusten BL
    Minerva Chir; 2018 Aug; 73(4):428-436. PubMed ID: 29658684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma.
    Ni W; Yu S; Zhang W; Xiao Z; Zhou Z; Chen D; Feng Q; Liang J; Lv J; Gao S; Mao Y; Xue Q; Sun K; Liu X; Fang D; Li J; Wang D
    BMC Cancer; 2020 Feb; 20(1):130. PubMed ID: 32070309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Endoscopic Submucosal Dissection vs Esophagectomy for T1 Esophageal Squamous Cell Carcinoma in a Real-World Cohort.
    Zhang Y; Ding H; Chen T; Zhang X; Chen WF; Li Q; Yao L; Korrapati P; Jin XJ; Zhang YX; Xu MD; Zhou PH
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):73-81.e3. PubMed ID: 29704682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salvage endoscopic submucosal dissection in patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma.
    Takeuchi M; Kobayashi M; Hashimoto S; Mizuno K; Kawaguchi G; Sasamoto R; Aoyama H; Aoyagi Y
    Scand J Gastroenterol; 2013 Sep; 48(9):1095-101. PubMed ID: 23906093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.